20-5-spiro CPT的化及其在体外抗癌活性
Yuan Liu1, Changkuo Zhao1, Huimin Liu1
1Department of Medicinal Chemistry, Zunyi Medical University, Zunyi City, China.
Natural product research
|April 8, 2024
概括
与原始化合物相比,合成了新的坎普托塞辛衍生物,显示出更好的溶解性和更强的抗癌活性对抗HepG2细胞.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症生物学 癌症生物学
背景情况:
- 坎普托西因是一种强大的抗癌剂,但其临床使用因溶解性差和毒性有限.
- 开发具有改善药理特征的新型坎普托塞辛衍生物对于有效的癌症治疗至关重要.
研究的目的:
- 合成新型20-的5-螺旋环坎普托他辛衍生物.
- 为了评估这些衍生物的溶解性和体外抗癌活性,与HepG2细胞系相比.
主要方法:
- 施特利希化用于合成20--5-螺旋环坎普托他辛衍生物.
- 评估了合成衍生品的可溶性.
- 对HepG2 (人类肝细胞癌) 细胞系的抑制活性进行了评估.
主要成果:
- 几种20--5-螺旋环坎普托他辛衍生物在中等产量中成功合成.
- 合成的衍生物与原始坎普托塞辛化合物相比,具有更强的溶解性.
- 大多数衍生品表现出对HepG2细胞的改善抑制活性,但3g化合物是例外.
结论:
- 合成的20--5-螺旋环坎普托他辛衍生物代表了一类有前途的化合物,具有改进的物理化学特性.
- 这些衍生品由于其增强的抗癌活性,有可能成为肝细胞癌治疗的新型治疗剂.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
